TABLE 1.

Lymph node lymphocytes of SIVmac-infected rhesus monkeys demonstrate Gag epitope-specific CTL function

Monkeya	% p11C, C-Mb-specific lysisc
	PBL		Lymph node
	ConA–IL-2 expanded (50/25/13)d	p11C, C-M expanded (5/3/1)	ConA–IL-2 expanded (50/25/13)	p11C, C-M expanded (5/3/1)
GL9	13/07/04	40/35/30	57/52/39	27/21/15
3K1	25/16/08	45/34/28	07/04/02	12/07/05
403	43/40/32	60/60/56	41/34/29	NTe
138	18/13/06	68/66/58	50/46/40	38/34/26
575	11/07/05	14/09/05	08/04/01	16/10/06
154	39/27/14	60/58/48	15/08/04	NT

^aChronically SIVmac-infected, Mamu-A*01⁺ rhesus monkeys. 

^bp11C, C-M represents the optimal 9-amino-acid fragment of the SIV Gag 12-amino-acid peptide p11C. 

^cPercent p11C, C-M-specific lysis was calculated as percent specific release by p11C, C-M-pulsed MHC class I-matched target cells minus the average of the percent release by control peptide p11B-pulsed target cells. The background level of p11B peptide-specific lysis was always less than 5% of the spontaneous release. 

^dE/T ratio. 

^eNT, not tested.